Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...

Explore the benefits and side effects of popular weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Learn how ...

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Novo Nordisk developed There’s Only One Ozempic in partnership with Rogue Producer, an independent advertising and content ...

As Ozempic, Wegovy, and Mounjaro transform bodies at record speed, experts say a new aesthetic consequence is becoming ...

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...

While talking about his efforts to lower the cost of weight-loss drugs, the president went on a tangent about one of his ...

Experts explain what ‘Ozempic neck’ is, why it happens after rapid weight loss and what treatment options are available ...

Novo Nordisk’s ‘There’s Only One Ozempic’ campaign is about reasserting the drugmaker’s brand name in an increasingly ...

Novo Nordisk's Q4 results hinge on Ozempic and Wegovy sales as demand growth slows amid guidance cuts due to intense rivalry ...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.